IBDEI1GF ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,23521,1,4,0)
 ;;=4^K90.0
 ;;^UTILITY(U,$J,358.3,23521,2)
 ;;=^20828
 ;;^UTILITY(U,$J,358.3,23522,0)
 ;;=D80.0^^78^1014^5
 ;;^UTILITY(U,$J,358.3,23522,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23522,1,3,0)
 ;;=3^Hypogammaglobulinemia,Hereditary
 ;;^UTILITY(U,$J,358.3,23522,1,4,0)
 ;;=4^D80.0
 ;;^UTILITY(U,$J,358.3,23522,2)
 ;;=^5002405
 ;;^UTILITY(U,$J,358.3,23523,0)
 ;;=D80.1^^78^1014^6
 ;;^UTILITY(U,$J,358.3,23523,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23523,1,3,0)
 ;;=3^Hypogammaglobulinemia,Nonfamilial
 ;;^UTILITY(U,$J,358.3,23523,1,4,0)
 ;;=4^D80.1
 ;;^UTILITY(U,$J,358.3,23523,2)
 ;;=^5002406
 ;;^UTILITY(U,$J,358.3,23524,0)
 ;;=D80.2^^78^1014^7
 ;;^UTILITY(U,$J,358.3,23524,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23524,1,3,0)
 ;;=3^IgA Immunodeficiency
 ;;^UTILITY(U,$J,358.3,23524,1,4,0)
 ;;=4^D80.2
 ;;^UTILITY(U,$J,358.3,23524,2)
 ;;=^5002407
 ;;^UTILITY(U,$J,358.3,23525,0)
 ;;=D83.8^^78^1014^2
 ;;^UTILITY(U,$J,358.3,23525,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23525,1,3,0)
 ;;=3^Common Variable Immunodeficiency,Other
 ;;^UTILITY(U,$J,358.3,23525,1,4,0)
 ;;=4^D83.8
 ;;^UTILITY(U,$J,358.3,23525,2)
 ;;=^5002436
 ;;^UTILITY(U,$J,358.3,23526,0)
 ;;=Q82.2^^78^1014^12
 ;;^UTILITY(U,$J,358.3,23526,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23526,1,3,0)
 ;;=3^Mastocytosis,General
 ;;^UTILITY(U,$J,358.3,23526,1,4,0)
 ;;=4^Q82.2
 ;;^UTILITY(U,$J,358.3,23526,2)
 ;;=^74444
 ;;^UTILITY(U,$J,358.3,23527,0)
 ;;=C96.21^^78^1014^13
 ;;^UTILITY(U,$J,358.3,23527,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23527,1,3,0)
 ;;=3^Mastocytosis,Systemic
 ;;^UTILITY(U,$J,358.3,23527,1,4,0)
 ;;=4^C96.21
 ;;^UTILITY(U,$J,358.3,23527,2)
 ;;=^5151294
 ;;^UTILITY(U,$J,358.3,23528,0)
 ;;=D84.81^^78^1014^9
 ;;^UTILITY(U,$J,358.3,23528,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23528,1,3,0)
 ;;=3^Immunodeficiency d/t Conditions Classified Elsewhere
 ;;^UTILITY(U,$J,358.3,23528,1,4,0)
 ;;=4^D84.81
 ;;^UTILITY(U,$J,358.3,23528,2)
 ;;=^5159114
 ;;^UTILITY(U,$J,358.3,23529,0)
 ;;=D84.821^^78^1014^10
 ;;^UTILITY(U,$J,358.3,23529,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23529,1,3,0)
 ;;=3^Immunodeficiency d/t Drugs
 ;;^UTILITY(U,$J,358.3,23529,1,4,0)
 ;;=4^D84.821
 ;;^UTILITY(U,$J,358.3,23529,2)
 ;;=^5159115
 ;;^UTILITY(U,$J,358.3,23530,0)
 ;;=D84.822^^78^1014^11
 ;;^UTILITY(U,$J,358.3,23530,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23530,1,3,0)
 ;;=3^Immunodeficiency d/t External Causes
 ;;^UTILITY(U,$J,358.3,23530,1,4,0)
 ;;=4^D84.822
 ;;^UTILITY(U,$J,358.3,23530,2)
 ;;=^5159116
 ;;^UTILITY(U,$J,358.3,23531,0)
 ;;=D84.89^^78^1014^8
 ;;^UTILITY(U,$J,358.3,23531,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23531,1,3,0)
 ;;=3^Immunodeficiencies,Other
 ;;^UTILITY(U,$J,358.3,23531,1,4,0)
 ;;=4^D84.89
 ;;^UTILITY(U,$J,358.3,23531,2)
 ;;=^5159117
 ;;^UTILITY(U,$J,358.3,23532,0)
 ;;=F17.210^^78^1015^8
 ;;^UTILITY(U,$J,358.3,23532,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23532,1,3,0)
 ;;=3^Nicotine Dependence,Uncompl
 ;;^UTILITY(U,$J,358.3,23532,1,4,0)
 ;;=4^F17.210
 ;;^UTILITY(U,$J,358.3,23532,2)
 ;;=^5003365
 ;;^UTILITY(U,$J,358.3,23533,0)
 ;;=F17.211^^78^1015^7
 ;;^UTILITY(U,$J,358.3,23533,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23533,1,3,0)
 ;;=3^Nicotine Dependence,In Remission
 ;;^UTILITY(U,$J,358.3,23533,1,4,0)
 ;;=4^F17.211
 ;;^UTILITY(U,$J,358.3,23533,2)
 ;;=^5003366
